Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.42 (market cap $6.04B), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $25.69 (market cap $141.25M). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 42.8× ProShares UltraShort Bloomberg Natural Gas ETF's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, ProShares UltraShort Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and ProShares UltraShort Bloomberg Natural Gas ETF for 10 Days on average.
| IOVA | KOLD | |
|---|---|---|
Market Cap | $6.04B | $141.25M |
Volume | 14,805,993 | 5,492,367 |
Sector | Health | Leveraged / Inverse |
52-Week High | $14.82 | $49.39 |
52-Week Low | $1.81 | $13.58 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $5.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KOLD is trading at $24.84, down 5.8% over the past 24 hours amid bearish technical signals. The stock faces significant selling pressure with moving averages indicating a strong downtrend, though oscillators remain neutral. Recent news highlights natural gas market volatility with record production levels and geopolitical tensions affecting energy sector sentiment. The stock currently trades near key support levels with resistance forming around $25-26.
The outlook remains challenging with bearish technical indicators and fundamental headwinds in the natural gas sector. Investment opportunities exist for contrarian investors betting on energy market recovery, but risks include continued production growth and weather-dependent demand. The stock's performance will likely track natural gas price movements and broader energy market dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About ProShares UltraShort Bloomberg Natural Gas ETF
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →
